Federal Circuit refuses to review Dolly the sheep ruling
The US Court of Appeals for the Federal Circuit has refused to grant an en banc review of its ruling that cloned animals made by methods that produced Dolly the sheep cannot be patented, according to Law360.
In May, the Federal Circuit affirmed a decision by the US Patent Trial and Appeal Board (PTAB), finding that while the method for creating a genetic clone can be patent protected, the clones themselves may not, as they do not have “markedly different characteristics from any found in nature”.
The patent examiner had rejected claims in the patent in 2008, finding them to be “anticipated and obvious”, which the PTAB later affirmed.
The named assignee of the patent application at suit, the Edinburgh-based Roslin Institute, said that it was not in a position to comment.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk